The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation

Biomaterials

Volumn 32, Issue 19, 2011, Pages 4317-4326

  Stachelek, Stanley J ^a   Finley, Matthew J ^a   Alferiev, Ivan S ^a   Wang, Fengxiang ^a   Tsai, Richard K ^b   Eckells, Edward C ^b   Tomczyk, Nancy ^c   Connolly, Jeanne M ^a   Discher, Dennis E ^b   Eckmann, David M ^c   Levy, Robert J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biomimetic material; Cell adhesion; Polyurethane; Polyvinyl chloride; Surface modification

Indexed keywords

CELL BINDING; EX-VIVO; FUNCTIONALIZED; FUNCTIONALIZED SURFACES; HUMAN BLOODS; HUMAN MONOCYTE-DERIVED MACROPHAGES; HUMAN NEUTROPHIL; IN-VITRO; INFLAMMATORY CELLS; METHOXY; MODIFIED POLYMER; MODIFIED PVC; NEUTRALIZING ANTIBODIES; OXIDATIVE DEGRADATION; PHOTOACTIVATION; POLYMERIC SURFACES; REGULATORY PROTEIN; SUB-DERMAL IMPLANTS; SURFACE MODIFICATION; TRANS-MEMBRANE PROTEINS; TYROSINE PHOSPHORYLATION;

ADHESION; AMINO ACIDS; ANIMAL CELL CULTURE; ANTIBODIES; BIOMIMETICS; CELL ADHESION; CELL CULTURE; CHLORINE COMPOUNDS; MACROPHAGES; PHOSPHORYLATION; POLYMERS; POLYVINYL CHLORIDES; SURFACES; TUBING;

CELL IMMOBILIZATION;

ADEFOVIR; CD47 ANTIGEN; NEUTRALIZING ANTIBODY; POLYMER; POLYURETHAN; POLYVINYLCHLORIDE; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; CELL INTERACTION; CELL STRAIN HL 60; CONTROLLED STUDY; INFLAMMATORY CELL; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; NONHUMAN; OXIDATION; PHOTOACTIVATION; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANTIGENS, CD47; ANTIGENS, DIFFERENTIATION; BIOCOMPATIBLE MATERIALS; CELL ADHESION; HL-60 CELLS; HUMANS; IMPLANTS, EXPERIMENTAL; INFLAMMATION; MACROPHAGES; MALE; MATERIALS TESTING; MOLECULAR STRUCTURE; PHOTOCHEMISTRY; POLYMERS; POLYURETHANES; POLYVINYL CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; SURFACE PROPERTIES;

RATTUS;

EID: 79955144288     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.053     Document Type: Article

References (38)

1. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science 2000, 290:84-89.
2. Subramanian S., Parthasarathy R., Sen S., Boder E.T., Discher D.E. Species- and cell type-specific interactions between CD47 and human SIRPalpha. Blood 2006, 107:2548-2556.
3. Olsson M., Nilsson A., Oldenborg P.A. Target cell CD47 regulates macrophage activation and erythrophagocytosis. Transfus Clin Biol 2006, 13:39-43.
4. Brown E.J., Frazier W.A. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 2001, 11:130-135.
5. Jaiswal S., Jamieson C.H., Pang W.W., Park C.Y., Chao M.P., Majeti R., et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009, 138:271-285.
6. Cameron C.M., Barrett J.W., Mann M., Lucas A., McFadden G. Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology 2005, 337:55-67.
7. Tsai R.K., Discher D.E. Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol 2008, 180:989-1003.
8. van den Berg T.K., van der Schoot C.E. Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation. Trends Immunol 2008, 29:203-206.
9. Oldenborg P.A., Zheleznyak A., Fang Y.F., Lagenaur C.F., Gresham H.D., Lindberg F.P. Role of CD47 as a marker of self on red blood cells. Science 2000, 288:2051-2054.
10. Stokes K., Urbanski P., Upton J. The in vivo auto-oxidation of polyether polyurethane by metal ions. J Biomater Sci Polym Ed 1990, 1:207-230.
11. Zapanta C.M., Griffith J.W., Hess G.D., Doxtater B.J., Khalapyan T., Pae W.E., et al. Microtextured materials for circulatory support devices: preliminary studies. ASAIO J 2006, 52:17-23.
12. Suh S.W., Kim W.G., Kim H.C., Min B.G. A new polymer valve for mechanical circulatory support systems. Int J Artif Organs 1996, 19:712-718.
13. Vernon-Wilson E.F., Kee W.J., Willis A.C., Barclay A.N., Simmons D.L., Brown M.H. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1. Eur J Immunol 2000, 30:2130-2137.
14. Stachelek S.J., Alferiev I., Choi H., Chan C.W., Zubiate B., Sacks M., et al. Prevention of oxidative degradation of polyurethane by covalent attachment of di-tert-butylphenol residues. J Biomed Mater Res A 2006, 78:653-661.
15. Stachelek S.J., Alferiev I., Choi H., Kronsteiner A., Uttayarat P., Gooch K.J., et al. Cholesterol-derivatized polyurethane: characterization and endothelial cell adhesion. J Biomed Mater Res A 2005, 72:200-212.
16. Chorny M., Fishbein I., Alferiev I.S., Nyanguile O., Gaster R., Levy R.J. Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression. Mol Ther 2006, 14:382-391.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
18. Stachelek S.J., Alferiev I., Fulmer J., Ischiropoulos H., Levy R.J. Biological stability of polyurethane modified with covalent attachment of di-tert-butyl-phenol. J Biomed Mater Res A 2007, 82:1004-1011.
19. Stachelek S.J., Alferiev I., Ueda M., Eckels E.C., Gleason K.T., Levy R.J. Prevention of polyurethane oxidative degradation with phenolic antioxidants covalently attached to the hard segments: structure-function relationships. J Biomed Mater Res A 2010, 94:751-759.
20. Subramanian S., Boder E.T., Discher D.E. Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site. J Biol Chem 2007, 282:1805-1818.
21. Chandler A.B. In vitro thrombotic coagulation of the blood; a method for producing a thrombus. Lab Invest 1958, 7:110-114.
22. Mutch N.J., Moore N.R., Mattsson C., Jonasson H., Green A.R., Booth N.A. The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitro. Br J Pharmacol 2008, 153:124-131.
23. Stevens K.N., Aldenhoff Y.B., van der Veen F.H., Maessen J.G., Koole L.H. Bioengineering of improved biomaterials coatings for extracorporeal circulation requires extended observation of blood-biomaterial interaction under flow. J Biomed Biotechnol 2007, 2007:29464.
24. Kudlova M., Kolackova M., Kunes P., Lonsky V., Mand'ak J., Ctirad A., et al. Expression of an activated form of integrin beta2 chain CD18 in cardiac surgical operations. Acta Med (Hradec Kralove) 2007, 50:187-193.
25. Zen K., Parkos C.A. Leukocyte-epithelial interactions. Curr Opin Cell Biol 2003, 15:557-564.
26. Christenson E.M., Anderson J.M., Hiltner A. Oxidative mechanisms of poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo and in vitro correlations. J Biomed Mater Res A 2004, 70:245-255.
27. Fukui Y., Funakubo A., Kawamura T. Development of an intra blood circuit membrane oxygenator. ASAIO J 1994, 40:M732-M734.
28. Karimova A., Robertson A., Cross N., Smith L., O'Callaghan M., Tuleu C., et al. A wet-primed extracorporeal membrane oxygenation circuit with hollow-fiber membrane oxygenator maintains adequate function for use during cardiopulmonary resuscitation after 2 weeks on standby. Crit Care Med 2005, 33:1572-1576.
29. Bruck S.D. Medical applications of polymeric materials. Med Prog Technol 1982, 9:1-16.
30. Edmunds L.H. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998, 66:S12-S16. discussion S25-8.
31. Levy J.H., Tanaka K.A. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003, 75:S715-S720.
32. Draaisma A.M., Hazekamp M.G. Coated versus noncoated circuits in pediatric cardiopulmonary bypass. ASAIO J 2005, 51:663-664.
33. Sohn N., Marcoux J., Mycyk T., Krahn J., Meng Q. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress. Perfusion 2009, 24:231-237.
34. Yoshizaki T., Tabuchi N., van Oeveren W., Shibamiya A., Koyama T., Sunamori M. PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation. Int J Artif Organs 2005, 28:834-840.
35. Paugam C., Chollet-Martin S., Dehoux M., Chatel D., Brient N., Desmonts J.M., et al. Neutrophil expression of CD11b/CD18 and IL-8 secretion during normothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997, 11:575-579.
36. Oldenborg P.A. Role of CD47 in erythroid cells and in autoimmunity. Leuk Lymphoma 2004, 45:1319-1327.
37. Tsai R.K., Rodriguez P.L., Discher D.E. Self inhibition of phagocytosis: the affinity of ' marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels. Blood Cells Mol Dis 2010, 45:67-74.
38. Ueda M., Alferiev I.S., Simons S.B., Hebbel R.P., Levy R.J., Stachelek S.J. CD47-dependent molecular mechanisms of blood outgrowth endothelial cell attachment on cholesterol-modified polyurethane. Biomaterials 2010, 31:6394-6399.